Ac immune announces upcoming presentations at ad/pd™ 2024

Ac immune announces upcoming presentations at ad/pd™ 2024 multiple presentations at the international conference on alzheimer's and parkinson's diseases (ad/pd™ 2024) andrea pfeifer, ph.d., ceo to lead ac immune-sponsored symposium on alpha-synuclein pathologies lausanne, switzerland, february 22, 2024 – ac immune sa (nasdaq: aciu), a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced upcoming presentations highlighting its precision medicine pipeline at the international conference on alzheimer's and parkinson's diseases (ad/pd™ 2024), taking place in lisbon, portugal march 5-9, 2024.
ACIU Ratings Summary
ACIU Quant Ranking